Cite
HARVARD Citation
Ravindra, S. et al. (n.d.). Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience. Lung cancer. pp. S46-. [Online].